- Home
- usa washington
- Equipment
Refine by
Applications
- Solution for Clinical Trials
- Solution for Access to Investigational Medicines
- Multi-Function Ventilator for Healthcare Professionals
- Trauma and Post-Traumatic Stress Disorder System (PTSD) for Health Plans
- Trauma and Post-Traumatic Stress Disorder System (PTSD) for Employers
- Trauma and Post-Traumatic Stress Disorder System (PTSD) for Veterans
- Trauma and Post-Traumatic Stress Disorder System (PTSD) for Individuals
- Software Solutions for Deep Mutational Scanning & Selection
- Software Solutions for COVID-19
Medical Equipment Supplied In Washington
540 equipment items found
Manufactured by:Bodypoint Inc. based inSeattle, WASHINGTON (USA)
Our Stayflex™ Chest Support gives firm support to users needing trunk control with more freedom of movement in the shoulders than the PivotFit or Trimline Shoulder Harnesses. The patented dual-stretch-zone construction virtually eliminates upward shift at the neckline when the user leans forward, minimizing strangulation risk. Available in Standard and Narrow Width styles. Narrow Width ...
Manufactured by:Bodypoint Inc. based inSeattle, WASHINGTON (USA)
For those needing focused shoulder retraction, the Trimline features two separate, adjustable padded straps that comfortably accommodate asymmetry while keeping the chest clear for maximum freedom of movement. New MD (multi-directional) Pull Straps can be configured as either a front-pull or rear-pull at the time of the fitting to better accommodate individual user needs. No need to choose pull ...
Manufactured by:Bodypoint Inc. based inSeattle, WASHINGTON (USA)
Evoflex® Belt Extender can be used to add up to 12.5cm (5") length on each ...
Manufactured by:Aseptico based inWoodinville, WASHINGTON (USA)
The 7000 Series Implant Motor is the most reliable, accurate, and comprehensive implant motor on the market today. Includes built-in LED ...
Manufactured by:AST, Inc. based inTacoma, WASHINGTON (USA)
The GENiSYS® R system is designed for aseptic fill-finish applications, providing automated capabilities that ensure compliance with stringent cGMP requirements. It's capable of processing a variety of ready-to-fill vial, syringe, and cartridge formats, making it suitable for both clinical and small-batch commercial production. The modular design allows for customization to meet specific ...
Manufactured by:AST, Inc. based inTacoma, WASHINGTON (USA)
AST's Benchtop Container Filling System is a semi-automatic machine designed for small batch processing of sterile injectable products, focusing on filling pre-filled syringes, cartridges, vials, and bottles. Embracing cGMP standards, its aseptic design is compatible with environments such as cleanrooms and aseptic isolators. It features an integrated peristaltic pump that ensures precise ...
Manufactured by:CurvaFix, Inc. based inBellevue, WASHINGTON (USA)
Curved implant for curved bones of the pelvis. The CurvaFix IM Implant is the first, new intramedullary pelvic trauma technology in 30 years, and is the only device capable of following the natural bone shape and filling the space within the pelvis. Unlike straight screws which can’t follow the natural curvature of intramedullary pathways (limiting use), and bone plates which require an ...
Manufactured by:Iasis Molecular Science based inSpokane, WASHINGTON (USA)
Our platform No. 1 antiseptics are a family of novel silver-based complexes for the treatment of wound infections and for use as the active component of antimicrobial medical device coatings. These antiseptics offer excellent potency against drug-resistant pathogens, little concern of selection for resistance, lower cellular toxicity, and process benefits not found with commercial antiseptics. ...
Manufactured by:Iasis Molecular Science based inSpokane, WASHINGTON (USA)
Our platform No. 2 antimicrobial additives can be broadly applicable across medical, consumer and industrial markets. A wide variety of derivatives have been synthesized. In the medical device space silver (Ag+) and quaternary ammonium compounds (QACs) have been explored. Modified acrylic latex enamel paint with various actives has been shown to be extensively antimicrobial, antiviral and ...
Manufactured by:Cancer Targeted Technology based inWoodinville, WASHINGTON (USA)
CTT’s lead therapeutic product, CTT1403, is a PSMA-targeted 177Lu-labeled agent for prostate cancer that can has superior binding characteristics, long circulation half-life, enhanced tumor uptake and unparalleled anti-tumor efficacy. CTT1403 will specifically deliver the radionuclide, 177Lu, minimizing toxic side effects and more effectively treating metastatic prostate cancer and other ...
Manufactured by:CHISON Medical Technologies Co., Ltd. based inWuxi, CHINA
Prime Choice for Cardiovascular, OB and GI. High-end portable ultrasound for sale. Premium imaging quality with advanced technologies. Intelligence-driven workflow offers a great ...
Manufactured by:CHISON Medical Technologies Co., Ltd. based inWuxi, CHINA
CHISON SonoEye can help to provide high quality patient care in any location. Featuring an adaptable design that goes from pad to mobile phone, increasing the portability, and making it possible to work together with doctors from patient to patient all the time, initially in point of care applications and longer terms in primary ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
Mechanism: ATM inhibitor; Area under investigation: glioblastoma; Date commenced phase: Q2 2018; Estimated Filing Acceptance: US: EU: Japan: China. Additional information. Molecule size: Small molecule Status ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
Mechanism: CDK9 inhibitor Area under investigation: haematalogical malignancies Date commenced phase: Q4 2017 Estimated Filing Acceptance: US: EU: Japan: China. Additional information. Molecule size: Small molecule Status change: New to Phase ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
Mechanism: Podocyte health; Area under investigation: nephropathy; Date commenced phase: Q1 2020; Estimated Filing Acceptance: US: EU: Japan: China. Additional information. Molecule size: Small molecule; Status ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
Mechanism: NASH resolution; Area under investigation: NASH; Date commenced phase: Q4 2019; Estimated Filing Acceptance: US: EU: Japan: China. Additional information. Molecule size: Small molecule; Status ...
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
Zymeworks’ lead product candidate, zanidatamab, is a HER2-targeted bispecific antibody developed using Zymeworks proprietary Azymetric platform. Zanidatamab is currently being evaluated in global Phase 1, Phase 2 and pivotal clinical trials as a best-in-class treatment for patients with HER2-expressing cancers, including biliary tract, gastroesophageal adenocarcinomas, breast, and other ...
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
ZW49 is a HER2-targeted antibody drug conjugate (ADC) developed using Zymeworks’ proprietary Azymetric™ and ZymeLink™ platforms. ZW49 is currently being evaluated in a Phase 1 clinical trial as a treatment for patients with locally advanced or metastatic HER2-expressing cancers that have progressed following treatment with existing approved therapies, including HER2-targeted ...
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
by creating tailored multifunctional therapeutics that enable enhanced efficacy and new biological approaches for treating diseases. Two is better than one. Create novel mechanisms of action through unique binding. Azymetric™ is the best-in-class platform for therapeutic antibodies that can simultaneously bind to multiple distinct locations on a target or to multiple targets, resulting in ...
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
with a modular suite of proprietary cytotoxins (cell-killing compounds), stable linkers, and conjugation technologies. A broader window of opportunity. Deliver potent cell-killing compounds specifically to diseased target cells with optimal safety and efficacy. ZymeLink™, a next-generation antibody drug conjugate (ADC) platform, is a suite of proprietary cytotoxins (cell-killing compounds), ...